|
NUP43 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.830200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.640200E-01 |
| Normal-vs-Stage2 |
4.245600E-01 |
| Normal-vs-Stage3 |
2.673800E-01 |
| Normal-vs-Stage4 |
4.706800E-01 |
| Stage1-vs-Stage2 |
3.091600E-01 |
| Stage1-vs-Stage3 |
1.190440E-01 |
| Stage1-vs-Stage4 |
3.827200E-01 |
| Stage2-vs-Stage3 |
7.722800E-01 |
| Stage2-vs-Stage4 |
9.253000E-01 |
| Stage3-vs-Stage4 |
8.835800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.259600E-01 |
| Normal-vs-AfricanAmerican |
5.042200E-01 |
| Normal-vs-Asian |
5.740000E-02 |
| Caucasian-vs-AfricanAmerican |
7.455800E-01 |
| Caucasian-vs-Asian |
1.284360E-01 |
| AfricanAmerican-vs-Asian |
1.202170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.866400E-01 |
| Normal-vs-Female |
5.218500E-02 |
| Male-vs-Female |
8.770000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.134400E-01 |
| Normal-vs-Extreme_Weight |
2.863200E-01 |
| Normal-vs-Obese |
2.623800E-02 |
| Normal-vs-Extreme_Obese |
9.953800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.509800E-01 |
| Normal_Weight-vs-Obese |
8.898400E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.973600E-01 |
| Extreme_Weight-vs-Obese |
1.138750E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.171200E-01 |
| Obese-vs-Extreme_Obese |
2.848600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.744200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.521500E-02 |
| Normal-vs-Age(61-80Yrs) |
6.081000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.269700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.835200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.899600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.860480E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.916380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.295100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.560200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.467700E-02 |
| Normal-VS-Type2 PRCC |
6.408200E-01 |
| Normal-VS-KIRP CIMP |
2.135000E-01 |
| Normal-VS-Unclassified PRCC |
8.111800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.386300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.011600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.271200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.060180E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.667800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.318800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.035600E-01 |
| Normal-vs-N1 |
5.583800E-02 |
| Normal-vs-N2 |
4.372100E-02 |
| N0-vs-N1 |
2.356300E-02 |
| N0-vs-N2 |
2.406600E-01 |
| N1-vs-N2 |
9.219700E-02 |
|
|
